Literature DB >> 21150374

Long-term follow-up of newborn screening patients.

Susan A Berry1, Michele A Lloyd-Puryear, Michael S Watson.   

Abstract

New technology in newborn screening permits clinicians to approach strategies for defining optimal treatments for newborn-screened conditions. The Health Resources and Services Administration Maternal and Child Health Bureau, the Eunice Kennedy Shriver National Institute of Child Health and Human Development, and the Centers for Disease Control and Prevention have all established initiatives for long-term follow-up assessment of children identified after newborn screening. In October 2008, an inaugural meeting of the National Institute of Child Health and Human Development-sponsored National Coordinating Center Long-Term Follow-Up Data Collection Work Group brought together partners from Health Resources and Services Administration-sponsored Regional Genetics Collaboratives to review pilot projects undertaken to promote systematic long-term follow-up for children with inborn errors of metabolism identified by newborn bloodspot screening. Beginning with these projects, the goal of this meeting was to provide a foundation for national planning for a common data set to be used for long-term follow-up. This supplement summarizes these initial projects.

Entities:  

Mesh:

Year:  2010        PMID: 21150374     DOI: 10.1097/GIM.0b013e3181fea476

Source DB:  PubMed          Journal:  Genet Med        ISSN: 1098-3600            Impact factor:   8.822


  8 in total

1.  Transient hypothyroidism at 3-year follow-up among cases of congenital hypothyroidism detected by newborn screening.

Authors:  Steven J Korzeniewski; Violanda Grigorescu; Mary Kleyn; William I Young; Gretchen Birbeck; David Todem; Roberto Romero; Nigel Paneth
Journal:  J Pediatr       Date:  2012-08-09       Impact factor: 4.406

Review 2.  Retention and research use of residual newborn screening bloodspots.

Authors:  Jeffrey R Botkin; Aaron J Goldenberg; Erin Rothwell; Rebecca A Anderson; Michelle Huckaby Lewis
Journal:  Pediatrics       Date:  2012-12-03       Impact factor: 7.124

3.  Applying public health screening criteria: how does universal newborn screening compare to universal tumor screening for Lynch syndrome in adults with colorectal cancer?

Authors:  Deborah Cragun; Rita D DeBate; Tuya Pal
Journal:  J Genet Couns       Date:  2014-10-18       Impact factor: 2.537

4.  Experiences of Families Caring for Children with Newborn Screening-Related Conditions: Implications for the Expansion of Genomics in Population-Based Neonatal Public Health Programs.

Authors:  Lynn Bush; Hannah Davidson; Shani Gelles; Dawn Lea; Laura M Koehly
Journal:  Int J Neonatal Screen       Date:  2022-05-23

5.  Primary Care Provider Management of Congenital Hypothyroidism Identified Through Newborn Screening.

Authors:  N A Rosenthal; E Bezar; S Mann; L K Bachrach; S Banerjee; M E Geffner; M Gottschalk; S K Shapira; L Hasegawa; L Feuchtbaum
Journal:  Ann Thyroid Res       Date:  2017-04-18

6.  A framework for assessing outcomes from newborn screening: on the road to measuring its promise.

Authors:  Cynthia F Hinton; Charles J Homer; Alexis A Thompson; Andrea Williams; Kathryn L Hassell; Lisa Feuchtbaum; Susan A Berry; Anne Marie Comeau; Bradford L Therrell; Amy Brower; Katharine B Harris; Christine Brown; Jana Monaco; Robert J Ostrander; Alan E Zuckerman; Celia Kaye; Denise Dougherty; Carol Greene; Nancy S Green
Journal:  Mol Genet Metab       Date:  2016-05-31       Impact factor: 4.797

7.  Developing a public health-tracking system for follow-up of newborn screening metabolic conditions: a four-state pilot project structure and initial findings.

Authors:  Cynthia F Hinton; Cara T Mai; Sarah K Nabukera; Lorenzo D Botto; Lisa Feuchtbaum; Paul A Romitti; Ying Wang; Kimberly Noble Piper; Richard S Olney
Journal:  Genet Med       Date:  2013-12-05       Impact factor: 8.822

8.  A population-based registry as a source of health indicators for rare diseases: the ten-year experience of the Veneto Region's rare diseases registry.

Authors:  Monica Mazzucato; Laura Visonà Dalla Pozza; Silvia Manea; Cinzia Minichiello; Paola Facchin
Journal:  Orphanet J Rare Dis       Date:  2014-03-19       Impact factor: 4.123

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.